Proteomic analysis identifies differentially expressed proteins after red propolis treatment in Hep-2 cells (original) (raw)

Abstract

Here we investigated alterations in the protein profile of Hep-2 treated with red propolis using two-dimensional electrophoresis associated to mass spectrometry and apoptotic rates of cells treated with and without red propolis extracts through TUNEL and Annexin-V assays. A total of 325 spots were manually excised from the two-dimensional gel electrophoresis and 177 proteins were identified using LC-MS-MS. Among all proteins identified that presented differential expression, most were downregulated in presence of red propolis extract at a concentration of 120 lg/mL (IC50): GRP78, PRDX2, LDHB, VIM and TUBA1A. Only two up-regulated proteins were identified in this study in the noncytotoxic (6 lg/mL) red propolis treated group: RPLP0 and RAD23B. TUNEL staining assay showed a markedly increase in the mid-to late-stage apoptosis of Hep-2 cells induced by red propolis at concentrations of 60 and 120 lg/mL when compared with non-treated cells. The increase of late apoptosis was confirmed by in situ Annexin-V analysis in which red propolis extract induced late apoptosis in a dosedependent manner. The differences in tumor cell protein profiles warrant further investigations including isolation of major bioactive compounds of red propolis in different cell lines using proteomics and molecular tests to validate the protein expression here observed.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (84)

  1. Abbasi, R., Ramroth, H., Becher, H., Dietz, A., Schmezer, P., Popanda, O., 2009. Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int. J. Cancer 125, 1431-1439.
  2. Akyol, S., Ozturk, G., Ginis, Z., Armutcu, F., Yigitoglu, M.R., Akyol, O., 2013. In vivo and in vitro antineoplastic actions of caffeic acid phenethyl ester (CAPE): therapeutic perspectives. Nutr. Cancer 65, 515-526.
  3. Alencar, S.M., Oldoni, T.L., Castro, M.L., Cabral, I.S., Costa-Neto, C.M., Cury, J.A., Rosalen, P.L., Ikegaki, M., 2007. Chemical composition and biological activity of a new type of Brazilian propolis: red propolis. J. Ethnopharmacol. 113, 278-283.
  4. Aso, K., Kanno, S., Tadano, T., Satoh, S., Ishikawa, M., 2004. Inhibitory effect of propolis on the growth of human leukemia U937. Biol. Pharm. Bull. 27, 727- 730.
  5. Baek, Y.M., Hwang, H.J., Kim, S.W., Hwang, H.S., Lee, S.H., Kim, J.A., Yun, J.W., 2008. A comparative proteomic analysis for capsaicin-induced apoptosis between human hepatocarcinoma (HepG2) and human neuroblastoma (SK-N-SH) cells. Proteomics 8, 4748-4767.
  6. Barreto, A.L.S., 2008. Estudo histomorfológico do efeito de membranas de colágeno contendo própolis vermelha sobre o processo de reparo cicatricial por segunda intenção em ratos. Universidade Tiradentes, Aracaju.
  7. Bergink, S., Toussaint, W., Luijsterburg, M.S., Dinant, C., Alekseev, S., Hoeijmakers, J.H., Dantuma, N.P., Houtsmuller, A.B., Vermeulen, W., 2012. Recognition of DNA damage by XPC coincides with disruption of the XPC-RAD23 complex. J. Cell Biol. 196, 681-688.
  8. Bianchi, L., Bruzzese, F., Leone, A., Gagliardi, A., Puglia, M., Di Gennaro, E., Rocco, M., Gimigliano, A., Pucci, B., Armini, A., Bini, L., Budillon, A., 2011. Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells. Proteomics 11, 3725- 3742.
  9. Bozzuto, G., Ruggieri, P., Molinari, A., 2010. Molecular aspects of tumor cell migration and invasion. Ann. Ist Super Sanita 46, 66-80.
  10. Brockstedt, E., Rickers, A., Kostka, S., Laubersheimer, A., Dorken, B., Wittmann- Liebold, B., Bommert, K., Otto, A., 1998. Identification of apoptosis- associated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleoprotein A1 by caspase 3. J. Biol. Chem. 273, 28057-28064.
  11. Burdock, G.A., 1998. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem. Toxicol. 36, 347-363.
  12. Cabral, I.S.R., Oldoni, T.L.C., Prado, A., Bezerra, R.M.N., Alencar, S.M.d., 2009. Composição fenólica, atividade antibacteriana e antioxidante da própolis vermelha brasileira. Quim Nova 32, 1523-1527.
  13. Cao, S., Xu, W., Zhang, N., Wang, Y., Luo, Y., He, X., Huang, K., 2012. A mitochondria- dependent pathway mediates the apoptosis of GSE-induced yeast. PLoS One 7, e32943.
  14. Castaldo, S., Capasso, F., 2002. Propolis, an old remedy used in modern medicine. Fitoterapia 73, S1-S6.
  15. Chang, Y.J., Huang, Y.P., Li, Z.L., Chen, C.H., 2012. GRP78 knockdown enhances apoptosis via the down-regulation of oxidative stress and Akt pathway after epirubicin treatment in colon cancer DLD-1 cells. PLoS One 7, e35123.
  16. Chen, L.F., Cohen, E.E., Grandis, J.R., 2010. New strategies in head and neck cancer: understanding resistance to epidermal growth factor receptor inhibitors. Clin. Cancer Res. 16, 2489-2495.
  17. Chiu, C.C., Lin, C.Y., Lee, L.Y., Chen, Y.J., Kuo, T.F., Chang, J.T., Liao, C.T., Wang, H.M., Yen, T.C., Shen, C.R., Liao, S.K., Cheng, A.J., 2008. Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention. Mol. Cancer Ther. 7, 2788-2797.
  18. Chuthapisith, S., Layfield, R., Kerr, I.D., Hughes, C., Eremin, O., 2007. Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs. Int. J. Oncol. 30, 1545-1551.
  19. Daugsch, A., Moraes, C.S., Fort, P., Park, Y.K., 2008. Brazilian red propolis-chemical composition and botanical origin. Evid Based Complement Alternat Med 5, 435- 441.
  20. Almeida, E.B., Cordeiro Cardoso, J., Karla de Lima, A., de Oliveira, N.L., de Pontes- Filho, N.T., Oliveira Lima, S., Leal Souza, I.C., de Albuquerque-Junior, R.L., 2013. The incorporation of Brazilian propolis into collagen-based dressing films improves dermal burn healing. J. Ethnopharmacol. 147, 419-425.
  21. Eom, H.S., Lee, E.J., Yoon, B.S., Yoo, B.S., 2010. Propolis inhibits the proliferation of human leukaemia HL-60 cells by inducing apoptosis through the mitochondrial pathway. Nat. Prod. Res. 24, 375-386.
  22. Franchi Jr, G.C., Moraes, C.S., Toreti, V.C., Daugsch, A., Nowill, A.E., Park, Y.K., 2012. Comparison of effects of the ethanolic extracts of brazilian propolis on human leukemic cells as assessed with the MTT assay. Evid Based Complement Alternat Med. http://dx.doi.org/10.1155/2012/918956.
  23. Friedberg, E.C., 2001. How nucleotide excision repair protects against cancer. Nat. Rev. Cancer 1, 22-33.
  24. Frozza, C.O., Garcia, C.S., Gambato, G., de Souza, M.D., Salvador, M., Moura, S., Padilha, F.F., Seixas, F.K., Collares, T., Borsuk, S., Dellagostin, O.A., Henriques, J.A., Roesch-Ely, M., 2013. Chemical characterization, antioxidant and cytotoxic activities of Brazilian red propolis. Food Chem. Toxicol. 52, 137-142.
  25. Garrido, C., Gurbuxani, S., Ravagnan, L., Kroemer, G., 2001. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem. Biophys. Res. Commun. 286, 433-442.
  26. Gavert, N., Ben-Ze'ev, A., 2008. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol. Med. 14, 199-209.
  27. Haddad, Y., Choi, W., McConkey, D.J., 2009. Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma lines. Clin. Cancer Res. 15, 532-542.
  28. Ho, J., Barbi de Moura, M., Lin, Y., Vincent, G., Thorne, S., Duncan, L.M., Lin, H.M., Kirkwood, J.M., Becker, D., van Houten, B., Moschos, S., 2012. Importance of glycolysis and oxidative phosphorylation in advanced melanoma. Mol. Cancer 11, 76. Hodgkinson, V.C., Agarwal, V., D, E.L., Fox, J.N., McManus, P.L., Mahapatra, T.K., Kneeshaw, P.J., Drew, P.J., Lind, M.J., Cawkwell, L., 2012. Pilot and feasibility study: comparative proteomic analysis by 2-DE MALDI TOF/TOF MS reveals 14- 3-3 proteins as putative biomarkers of response to neoadjuvant chemotherapy in ER-positive breast cancer. J. Proteomics 75, 2745-2752.
  29. Honore, B., Buus, S., Claesson, M.H., 2008. Identification of differentially expressed proteins in spontaneous thymic lymphomas from knockout mice with deletion of p53. Proteome Sci. 6, 18.
  30. Hussien, R., Brooks, G.A., 2011. Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines. Physiol. Genomics 43, 255-264.
  31. Janicijevic, A., Sugasawa, K., Shimizu, Y., Hanaoka, F., Wijgers, N., Djurica, M., Hoeijmakers, J.H., Wyman, C., 2003. DNA bending by the human damage recognition complex XPC-HR23B. DNA Repair (Amst) 2, 325-336.
  32. Ji, H., Moritz, R.L., Kim, Y.S., Zhu, H.J., Simpson, R.J., 2007. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics. Electrophoresis 28, 1997-2008.
  33. Jiang, C.C., Mao, Z.G., Avery-Kiejda, K.A., Wade, M., Hersey, P., Zhang, X.D., 2009. Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells. Carcinogenesis 30, 197-204.
  34. Kageyama, T., Nagashio, R., Ryuge, S., Matsumoto, T., Iyoda, A., Satoh, Y., Masuda, N., Jiang, S.X., Saegusa, M., Sato, Y., 2011. HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer. Asian Pac. J. Cancer Prev. 12, 3457-3463.
  35. Kahali, S., Sarcar, B., Fang, B., Williams, E.S., Koomen, J.M., Tofilon, P.J., Chinnaiyan, P., 2010. Activation of the unfolded protein response contributes toward the antitumor activity of vorinostat. Neoplasia 12, 80-86.
  36. Kamiya, T., Nishihara, H., Hara, H., Adachi, T., 2012. Ethanol extract of Brazilian red propolis induces apoptosis in human breast cancer MCF-7 cells through endoplasmic reticulum stress. J. Agric. Food Chem. 60, 11065-11070.
  37. Kavallaris, M., 2010. Microtubules and resistance to tubulin-binding agents. Nat. Rev. Cancer 10, 194-204.
  38. Kim, J.S., Chang, J.W., Yun, H.S., Yang, K.M., Hong, E.H., Kim, D.H., Um, H.D., Lee, K.H., Lee, S.J., Hwang, S.G., 2010. Chloride intracellular channel 1 identified using proteomic analysis plays an important role in the radiosensitivity of HEp-2 cells via reactive oxygen species production. Proteomics 10, 2589-2604.
  39. Kim, J.H., Kim, E.L., Lee, Y.K., Park, C.B., Kim, B.W., Wang, H.J., Yoon, C.H., Lee, S.J., Yoon, G., 2011. Decreased lactate dehydrogenase B expression enhances claudin 1-mediated hepatoma cell invasiveness via mitochondrial defects. Exp. Cell Res. 317, 1108-1118.
  40. Kinoshita, T., Nohata, N., Yoshino, H., Hanazawa, T., Kikkawa, N., Fujimura, L., Chiyomaru, T., Kawakami, K., Enokida, H., Nakagawa, M., Okamoto, Y., Seki, N., 2012. Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma. Int. J. Oncol. 40, 185-193.
  41. Koumenis, C., 2006. ER stress, hypoxia tolerance and tumor progression. Curr. Mol. Med. 6, 55-69.
  42. Lahat, G., Zhu, Q.S., Huang, K.L., Wang, S., Bolshakov, S., Liu, J., Torres, K., Langley, R.R., Lazar, A.J., Hung, M.C., Lev, D., 2010. Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies. PLoS One 5, e10105.
  43. Li, J., Lee, A.S., 2006. Stress induction of GRP78/BiP and its role in cancer. Curr. Mol. Med. 6, 45-54.
  44. Li, F., Awale, S., Tezuka, Y., Kadota, S., 2008. Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship. Bioorg. Med. Chem. 16, 5434-5440.
  45. Liu, R., Li, Z., Bai, S., Zhang, H., Tang, M., Lei, Y., Chen, L., Liang, S., Zhao, Y.L., Wei, Y., Huang, C., 2009. Mechanism of cancer cell adaptation to metabolic stress: proteomics identification of a novel thyroid hormone-mediated gastric carcinogenic signaling pathway. Mol. Cell Proteomics 8, 70-85.
  46. Lizarbe, M.A., Barrasa, J.I., Olmo, N., Gavilanes, F., Turnay, J., 2013. Annexin- phospholipid interactions. Functional implications. Int. J. Mol. Sci. 14, 2652- 2683.
  47. Lustosa, S.R., Galindo, A.B., Nunes, L.C.C., Randau, K.P., Neto, P.J.R., 2008. Própolis: atualizações sobre a química e a farmacologia. Rev. Bras. Farmacogn. 18, 447- 454.
  48. Maiti, A.K., 2012. Reactive oxygen species reduction is a key underlying mechanism of drug resistance in cancer chemotherapy. Chemotherapy 1. http://dx.doi.org/ 10.4172/2167-7700.1000104.
  49. Mhaidat, N., Jaradat, S., Aldaher, A., Ghabkari, A., 2011. Inhibition of GRP78 sensitizes colorectal cancer cells to paclitaxel-induced apoptosis by activation of caspase-4. Int. J. Biol. Biomed. Eng. 5, 41-48.
  50. Mukhopadhyay, S., Good, D., Miller, R.D., Graham, J.E., Mathews, S.A., Timms, P., Summersgill, J.T., 2006. Identification of Chlamydia pneumoniae proteins in the transition from reticulate to elementary body formation. Mol. Cell Proteomics 5, 2311-2318.
  51. Myung, J.K., Afjehi-Sadat, L., Felizardo-Cabatic, M., Slavc, I., Lubec, G., 2004. Expressional patterns of chaperones in ten human tumor cell lines. Proteome Sci. 2, 8.
  52. Neher, T.M., Rechkunova, N.I., Lavrik, O.I., Turchi, J.J., 2010. Photo-cross-linking of XPC-Rad23B to cisplatin-damaged DNA reveals contacts with both strands of the DNA duplex and spans the DNA adduct. Biochemistry 49, 669-678.
  53. Nodale, C., Sheffer, M., Jacob-Hirsch, J., Folgiero, V., Falcioni, R., Aiello, A., Garufi, A., Rechavi, G., Givol, D., D'Orazi, G., 2012. HIPK2 downregulates vimentin and inhibits breast cancer cell invasion. Cancer Biol. Ther. 13, 198-205.
  54. Noh, D.Y., Ahn, S.J., Lee, R.A., Kim, S.W., Park, I.A., Chae, H.Z., 2001. Overexpression of peroxiredoxin in human breast cancer. Anticancer Res. 21, 2085-2090.
  55. Okoli, A.S., Fox, E.M., Raftery, M.J., Mendz, G.L., 2007. Effects of Helicobacter hepaticus on the proteome of HEp-2 cells. Antonie Van Leeuwenhoek 92, 289- 300. Orsolic, N., Basic, I., 2003. Immunomodulation by water-soluble derivative of propolis: a factor of antitumor reactivity. J. Ethnopharmacol. 84, 265-273.
  56. Pan, T.L., Wang, P.W., Huang, C.C., Yeh, C.T., Hu, T.H., Yu, J.S., 2012. Network analysis and proteomic identification of vimentin as a key regulator associated with invasion and metastasis in human hepatocellular carcinoma cells. J. Proteomics 75, 4676-4692.
  57. Park, J.H., Kim, Y.S., Lee, H.L., Shim, J.Y., Lee, K.S., Oh, Y.J., Shin, S.S., Choi, Y.H., Park, K.J., Park, R.W., Hwang, S.C., 2006. Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. Respirology 11, 269-275.
  58. Piccinelli, A.L., Lotti, C., Campone, L., Cuesta-Rubio, O., Campo Fernandez, M., Rastrelli, L., 2011. Cuban and Brazilian red propolis: botanical origin and comparative analysis by high-performance liquid chromatography-photodiode array detection/electrospray ionization tandem mass spectrometry. J. Agric. Food Chem. 59, 6484-6491.
  59. Pinheiro, M.S., 2009. Avaliação da atividade antimicrobiana e citoprotetora gástrica dos extratos de mangaba, caju e própolis vermelha. Universidade Tiradentes, Aracaju.
  60. Reed, J.C., 2000. Methods in Enzymology. Academic Press, San Diego, CA.
  61. Righi, A.A., Alves, T.R., Negri, G., Marques, L.M., Breyer, H., Salatino, A., 2011. Brazilian red propolis: unreported substances, antioxidant and antimicrobial activities. J. Sci. Food Agric. 91, 2363-2370.
  62. Rodrigues-Lisoni, F.C., Peitl Jr., P., Vidotto, A., Polachini, G.M., Maniglia, J.V., Carmona-Raphe, J., Cunha, B.R., Henrique, T., Souza, C.F., Teixeira, R.A., Fukuyama, E.E., Michaluart Jr., P., de Carvalho, M.B., Oliani, S.M., Head Neck Genome Project, G., Tajara, E.H., Cury, P.M., de Carvalho, M.B., Dias-Neto, E., Figueiredo, D.L., Fukuyama, E.E., Gois-Filho, J.F., Leopoldino, A.M., Mamede, R.C., Michaluart-Junior, P., Moyses, R.A., Nobrega, F.G., Nobrega, M.P., Nunes, F.D., Ojopi, E.F., Serafini, L.N., Severino, P., Silva, A.M., Silva Jr., W.A., Silveira, N.J., Souza, S.C., Tajara, E.H., Wunsch-Filho, V., Amar, A., Bandeira, C.M., Braconi, M.A., Brandao, L.G., Brandao, R.M., Canto, A.L., Cerione, M., Cicco, R., Chagas, M.J., Chedid, H., Costa, A., Cunha, B.R., Curioni, O.A., Fortes, C.S., Franzi, S.A., Frizzera, A.P., Gazito, D., Guimaraes, P.E., Kaneto, C.M., Lopez, R.V., Macarenco, R., Magalhaes, M.R., Meneses, C., Mercante, A.M., Pinheiro, D.G., Polachini, G.M., Rapoport, A., Rodini, C.O., Rodrigues-Lisoni, F.C., Rodrigues, R.V., Rossi, L., Santos, A.R., Santos, M., Settani, F., Silva, F.A., Silva, I.T., Souza, T.B., Stabenow, E., Takamori, J.T., Valentim, P.J., Vidotto, A., Xavier, F.C., Yamagushi, F., Cominato, M.L., Correa, P.M., Mendes, G.S., Paiva, R., Ramos, O., Silva, C., Silva, M.J., Tarla, M.V., 2010. Genomics and proteomics approaches to the study of cancer-stroma interactions. BMC Med. Genomics 3, 14.
  63. Sahab, Z.J., Kirilyuk, A., Zhang, L., Khamis, Z.I., Pompach, P., Sung, Y., Byers, S.W., 2012. Analysis of tubulin alpha-1A/1B C-terminal tail post-translational poly- glutamylation reveals novel modification sites. J. Proteome Res. 11, 1913-1923.
  64. Sawicka, D., Car, H., Borawska, M.H., Niklinski, J., 2012. The anticancer activity of propolis. Folia Histochem. Cytobiol. 50, 25-37.
  65. Seda Vatansever, H., Sorkun, K., Ismet Deliloglu Gurhan, S., Ozdal-Kurt, F., Turkoz, E., Gencay, O., Salih, B., 2010. Propolis from Turkey induces apoptosis through activating caspases in human breast carcinoma cell lines. Acta Histochem. 112, 546-556.
  66. Semenza, G.L., 2008. Tumor metabolism: cancer cells give and take lactate. J. Clin. Invest. 118, 3835-3837.
  67. Sforcin, J.M., 2007. Propolis and the immune system: a review. J. Ethnopharmacol. 113, 1-14.
  68. Sforcin, J.M., Bankova, V., 2011. Propolis: is there a potential for the development of new drugs? J. Ethnopharmacol. 133, 253-260.
  69. Shen, K., Rice, S.D., Gingrich, D.A., Wang, D., Mi, Z., Tian, C., Ding, Z., Brower, S.L., Ervin Jr., P.R., Gabrin, M.J., Tseng, G., Song, N., 2012. Distinct genes related to drug response identified in ER positive and ER negative breast cancer cell lines. PLoS One 7, e40900.
  70. Silva, M.S.e.C., 2007. Estudo do efeito da fração BRVD obtida a partir da própolis brasileira tipificada, na proliferação de células tumorais. Universidade de São Paulo, São Paulo.
  71. Siqueira, A.B., Gomes, B.S., Cambuim, I., Maia, R., Abreu, S., Souza-Motta, C.M., de Queiroz, L.A., Porto, A.L., 2009. Trichophyton species susceptibility to green and red propolis from Brazil. Lett. Appl. Microbiol. 48, 90-96.
  72. Smith-Pearson, P.S., Kooshki, M., Spitz, D.R., Poole, L.B., Zhao, W., Robbins, M.E., 2008. Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2). Free Radic. Biol. Med. 45, 1178-1189.
  73. Soini, Y., Kallio, J.P., Hirvikoski, P., Helin, H., Kellokumpu-Lehtinen, P., Kang, S.W., Tammela, T.L., Peltoniemi, M., Martikainen, P.M., Kinnula, V.L., 2006. Oxidative/ nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma. APMIS 114, 329-337.
  74. Sonveaux, P., Vegran, F., Schroeder, T., Wergin, M.C., Verrax, J., Rabbani, Z.N., De Saedeleer, C.J., Kennedy, K.M., Diepart, C., Jordan, B.F., Kelley, M.J., Gallez, B., Wahl, M.L., Feron, O., Dewhirst, M.W., 2008. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J. Clin. Invest. 118, 3930-3942.
  75. Stresing, V., Baltziskueta, E., Rubio, N., Blanco, J., Arriba, M., Valls, J., Janier, M., Clézardin, P., Sanz-Pamplona, R., Nieva, C., Marro, M., Dmitri, P., Sierra, A., 2012. Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs. Oncogene 32, 724- 735. Sugasawa, K., Akagi, J., Nishi, R., Iwai, S., Hanaoka, F., 2009. Two-step recognition of DNA damage for mammalian nucleotide excision repair: directional binding of the XPC complex and DNA strand scanning. Mol. Cell 36, 642-653.
  76. Umthong, S., Phuwapraisirisan, P., Puthong, Songchan, Chanchao, Chanpen, 2011. In vitro antiproliferative activity of partially purified Trigona laeviceps propolis from Thailand on human cancer cell lines. BMC Complement Altern. Med. 11, 37. Valente, M.J., Baltazar, A.F., Henrique, R., Estevinho, L., Carvalho, M., 2011. Biological activities of Portuguese propolis: protection against free radical-induced erythrocyte damage and inhibition of human renal cancer cell growth in vitro. Food Chem. Toxicol. 49, 86-92.
  77. Vangestel, C., Van de Wiele, C., Mees, G., Peeters, M., 2009. Forcing cancer cells to commit suicide. Cancer Biother. Radiopharm. 24, 395-407.
  78. Wang, T., Tamae, D., LeBon, T., Shively, J.E., Yen, Y., Li, J.J., 2005. The role of peroxiredoxin II in radiation-resistant MCF-7 breast cancer cells. Cancer Res. 65, 10338-10346.
  79. Wang, M., Wey, S., Zhang, Y., Ye, R., Lee, A.S., 2009. Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. Antioxid. Redox. Signal 11, 2307-2316.
  80. Watanabe, M.A., Amarante, M.K., Conti, B.J., Sforcin, J.M., 2011. Cytotoxic constituents of propolis inducing anticancer effects: a review. J. Pharm. Pharmacol. 63, 1378-1386.
  81. Wilmet, J.P., Tastet, C., Desruelles, E., Ziental-Gelus, N., Blanckaert, V., Hondermarck, H., Le Bourhis, X., 2011. Proteome changes induced by overexpression of the p75 neurotrophin receptor (p75NTR) in breast cancer cells. Int. J. Dev. Biol. 55, 801-809.
  82. Zhang, J., Jiang, Y., Jia, Z., Li, Q., Gong, W., Wang, L., Wei, D., Yao, J., Fang, S., Xie, K., 2006. Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Clin. Exp. Metastasis 23, 401-410.
  83. Zhang, H., Cao, R., Lee, W.N., Deng, C., Zhao, Y., Lappe, J., Recker, R., Yen, Y., Wang, Q., Tsai, M.Y., Go, V.L., Xiao, G.G., 2010. Inhibition of protein phosphorylation in MIA pancreatic cancer cells: confluence of metabolic and signaling pathways. J. Proteome Res. 9, 980-989.
  84. Zhou, H., Zhang, Y., Fu, Y., Chan, L., Lee, A.S., 2011. Novel mechanism of anti- apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK). J. Biol. Chem. 286, 25687-25696.